144 related articles for article (PubMed ID: 7927199)
1. Transferrin soluble receptor: a possible probe for detection of erythropoietin abuse by athletes.
Gareau R; Gagnon MG; Thellend C; Chénard C; Audran M; Chanal JL; Ayotte C; Brisson GR
Horm Metab Res; 1994 Jun; 26(6):311-2. PubMed ID: 7927199
[No Abstract] [Full Text] [Related]
2. Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
Robinson N; Saugy M; Mangin P
Clin Lab; 2003; 49(1-2):57-62. PubMed ID: 12593476
[TBL] [Abstract][Full Text] [Related]
3. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.
Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Gargiullo E; Parisi A; Pigozzi F
Blood Cells Mol Dis; 2001; 27(3):559-71. PubMed ID: 11355895
[TBL] [Abstract][Full Text] [Related]
4. Preanalytical phase of soluble receptor of transferrin.
Banfi G
Int J Sports Med; 2007 Jan; 28(1):88-9. PubMed ID: 17203438
[No Abstract] [Full Text] [Related]
5. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
Lippi G; Franchini M; Guidi G
Haematologica; 2004 Apr; 89(4):ELT05. PubMed ID: 15075118
[No Abstract] [Full Text] [Related]
6. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
7. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
[TBL] [Abstract][Full Text] [Related]
8. Monitoring erythropoietin abuse in athletes.
Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Parisi A; Pigozzi F
Br J Haematol; 1999 Jul; 106(1):260-1. PubMed ID: 10444203
[No Abstract] [Full Text] [Related]
9. A third generation approach to detect erythropoietin abuse in athletes.
Sharpe K; Ashenden MJ; Schumacher YO
Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin abuse in athletes.
Gareau R; Audran M; Baynes RD; Flowers CH; Duvallet A; Senécal L; Brisson GR
Nature; 1996 Mar; 380(6570):113. PubMed ID: 8600382
[No Abstract] [Full Text] [Related]
11. Blood test may help discourage doping.
Expert Rev Mol Diagn; 2002 Mar; 2(2):95. PubMed ID: 11962345
[No Abstract] [Full Text] [Related]
12. Second-generation blood tests to detect erythropoietin abuse by athletes.
Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
[TBL] [Abstract][Full Text] [Related]
13. "Genetic Doping" with erythropoietin cDNA in primate muscle is detectable.
Lasne F; Martin L; de Ceaurriz J; Larcher T; Moullier P; Chenuaud P
Mol Ther; 2004 Sep; 10(3):409-10. PubMed ID: 15336641
[No Abstract] [Full Text] [Related]
14. Erythropoietin and blood doping.
Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
[TBL] [Abstract][Full Text] [Related]
15. Rogue athletes and recombinant DNA technology: challenges for doping control.
Azzazy HM; Mansour MM
Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
[TBL] [Abstract][Full Text] [Related]
16. How to confirm C.E.R.A. doping in athletes' blood?
Leuenberger N; Lamon S; Robinson N; Giraud S; Saugy M
Forensic Sci Int; 2011 Dec; 213(1-3):101-3. PubMed ID: 21889277
[TBL] [Abstract][Full Text] [Related]
17. Laboratory screening for erythropoietin abuse in sport: an emerging challenge.
Lippi G; Guidi G
Clin Chem Lab Med; 2000 Jan; 38(1):13-9. PubMed ID: 10774956
[TBL] [Abstract][Full Text] [Related]
18. Strengths and weaknesses of established indirect models to detect recombinant human erythropoietin abuse on blood samples collected 48-hr post administration.
Connes P; Caillaud C; Simar D; Villard S; Sicart MT; Audran M
Haematologica; 2004 Jul; 89(7):891-2. PubMed ID: 15257956
[TBL] [Abstract][Full Text] [Related]
19. [Medication, athletes and doping regulations].
Hartgens F
Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
[TBL] [Abstract][Full Text] [Related]
20. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?
Borrione P; Parisi A; Salvo RA; Spaccamiglio A; Pautasso M; Baraban D; Piccoli GB; Pigozzi F; Angeli A
J Biol Regul Homeost Agents; 2007; 21(3-4):79-88. PubMed ID: 18261259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
